Cell runs a lengthy correction, rather than retraction, for image problems

The journal Cell has an interesting — and somewhat puzzling — correction this month that we’ll add to our “mega-correction” file.

At issue is a paper, published in October, from the lab of Harvard’s Stephen Elledge, a noted genetics researcher, whose first author is a post-doc there named Michael Emanuele.

According to the notice, Emanuele (singled out, we note) seems to have been rather careless with the images used in the article, titled “Global Identification of Modular Cullin-RING Ligase Substrates”: Continue reading Cell runs a lengthy correction, rather than retraction, for image problems

Tsuji explains why JBC paper was retracted: Western blot problems

Last week, we reported on the retraction of a paper in the Journal of Biological Chemistry (JBC) that had one of the journal’s typically inscrutable retraction notices.:

This article has been withdrawn by the authors.

Late last week, we heard back from corresponding author Takashi Tsuji by email. It turns out one of our commenters had basically figured out what was wrong. It was, as seems to often be the case lately in retractions we cover, troubles with Western blots: Continue reading Tsuji explains why JBC paper was retracted: Western blot problems

University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern

Stefano Fiorucci, a gastroenterology researcher at the University of Perugia in Italy, has been indicted for fraud and embezzlement, after a university investigation found that he had manipulated images in papers that he used to win about 2 million Euros in grant funding.

The case, which has so far resulted in four retractions and nine Expressions of Concern, has dragged on for several years. The trial is scheduled for July. It’s the first time that embezzlement charges have been brought against a scientist found to have committed fraud, according to reports in Umbria 24 and the Umbria Journal.

Fiorucci’s attorney, Stefano Bagianti, told Umbria 24 that there was Continue reading University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern

Journal of Neurochemistry retracts paper after SUNY Upstate medical school finds evidence of fraud

Following an investigation by the State University of New York (SUNY) Upstate into the work of one of its neuroscientists, the Journal of Neurochemistry has retracted a 2007 paper.

The retraction notice is quite clear about why the paper is being withdrawn: Continue reading Journal of Neurochemistry retracts paper after SUNY Upstate medical school finds evidence of fraud

ORI roundup: Former SUNY grad student, two Kansas U researchers hit with sanctions

In two unrelated cases, the Office of Research Integrity (ORI) has sanctioned a grad student and a pair of colleagues, one of whom plagiarized and the other allowed the intellectual theft to go unchecked.

We think the handling of these cases — both first noted briefly by The Chronicle of Higher Education — is worth noting.

Continue reading ORI roundup: Former SUNY grad student, two Kansas U researchers hit with sanctions

Resveratrol fraud case update: Dipak Das loses editor’s chair, lawyer issues statement refuting all charges

Das, via UConn

Many Retraction Watch readers will now be familiar with the case of Dipak Das, the resveratrol researcher about whom the University of Connecticut issued a voluminous report yesterday — summary here — detailing 145 counts of data fabrication and falsification. This has been a fast-moving story, so we wanted to highlight a number of updates to our original post, and offer a few more.

First, we have confirmed with publisher Mary Ann Liebert this morning that Das has been relieved of his duties as co-editor in chief of Antioxidants & Redox Signaling. He had shared that post with Chandan Sen, and his name as been removed from the masthead of that journal. Here’s a statement from the publisher: Continue reading Resveratrol fraud case update: Dipak Das loses editor’s chair, lawyer issues statement refuting all charges

Journal retracts heart stem cell paper (and pulls no punches) over image fraud

Some retractions beg for a kick of sand in the face, and others do the kicking. Here’s an example of what Charles Atlas might have written had he been a journal editor concerned with research integrity.

Experimental Biology and Medicine, the official journal of the Society for Experimental Biology and Medicine, has retracted a 2010 article by a group of stem cell scientists in China with an unfortunate affinity for a particular figure—one they’d used in a previous publication, only with a different description.

Here’s the notice for the paper, “Isolation and characterization of multipotent progenitor cells from the human fetal aorta wall,” which was cited five times before it was retracted, according to Thomson Scientific’s Web of Knowledge: Continue reading Journal retracts heart stem cell paper (and pulls no punches) over image fraud

Chronic fatigue syndrome-XMRV paper retracted by Science, completely this time

The editors of Science have fully retracted a study they published in 2009 alleging a link between chronic fatigue syndrome (CFS) and the virus XMRV.

The notice begins with a nod to the reasons that the paper has already been partially retracted:

Science is fully retracting the Report “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome” (1). Multiple laboratories, including those of the original authors (2), have failed to reliably detect xenotropic murine leukemia virus–related virus (XMRV) or other murine leukemia virus (MLV)–related viruses in chronic fatigue syndrome (CFS) patients. In addition, there is evidence of poor quality control in a number of specific experiments in the Report. Fig. 1, table S1, and fig. S2 have been retracted by the authors (3).

It also refers to evidence of image manipulation that was described by blogger Abbie Smith and then reported in the Chicago Tribune:

Continue reading Chronic fatigue syndrome-XMRV paper retracted by Science, completely this time

Another Hattori retraction over reused figure from cardiology pub

Another paper in Diabetologia by Yoshiyuki Hattori has been retracted for image duplication, marking the second of his articles in the journal to be pulled for that reason.

The notice for the article, “A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells,” states: Continue reading Another Hattori retraction over reused figure from cardiology pub

Cardiff University misconduct investigation leads to Journal of Immunology retraction

The senior author of a Journal of Immunology paper has retracted it after a university investigation found that he had inappropriately manipulated images, Retraction Watch has learned.

Here’s the notice: Continue reading Cardiff University misconduct investigation leads to Journal of Immunology retraction